• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微脉管塌陷比例升高表明非小细胞肺癌患者的生存结局较差。

Elevated proportion of collapsed microvessels indicate poor survival outcome in patients with non-small cell lung cancer.

作者信息

Tong Ying-Hui, He Ying, Hu Lu-Ying, Liu Yu-Jia, Zheng Xiao-Wei, Sun Jiao, Song Yu, Zhang Yi-Wen, Fang Luo, Huang Ping

机构信息

Institute of Cancer Research and Basic Medical Sciences of Chinese Academy of Sciences, Cancer Hospital of University of Chinese Academy of Sciences, Zhejiang Cancer Hospital, Hangzhou, China.

Department of Pharmacy, Children's Hospital, School of Medicine, Zhejiang University, Hangzhou, China.

出版信息

Tumori. 2019 Dec;105(6):494-500. doi: 10.1177/0300891619871103. Epub 2019 Sep 3.

DOI:10.1177/0300891619871103
PMID:31478461
Abstract

BACKGROUND

An integral and well-functioning vascular system is essential for tumor progression and chemotherapy infusion. However, the lumen integrity of the microvessels and its significance in prognosis has not been studied. In this study, we found that the proportion of collapsed microvessels is suggested to be a novel biomarker for predicting prognosis in patients with non-small cell lung cancer (NSCLC).

METHODS

In this study, immunohistochemical CD31 staining was performed to identify the microvessels in tumor specimens. Proportions of collapsed vessels were estimated in CD31-stained tumor specimens from 100 patients with NSCLC. The correlation between collapsed microvessel proportion and survival time were evaluated by univariate and multivariate analysis.

RESULTS

Data from 99 patients were analyzed and a wide range of collapse-microvessel fraction was observed in 96 patients (1.4%-70%). Elevated collapse proportion (⩾6.5%) indicated poor overall survival in both univariate analysis ( = 0.042) and multivariate analysis ( = 0.014).

CONCLUSIONS

Elevated proportion of collapsed microvessels indicted poor survival outcome in patients with NSCLC.

摘要

背景

完整且功能良好的血管系统对于肿瘤进展和化疗药物输注至关重要。然而,微血管的管腔完整性及其在预后中的意义尚未得到研究。在本研究中,我们发现塌陷微血管的比例有望成为预测非小细胞肺癌(NSCLC)患者预后的一种新型生物标志物。

方法

在本研究中,采用免疫组织化学CD31染色来识别肿瘤标本中的微血管。对100例NSCLC患者的CD31染色肿瘤标本中塌陷血管的比例进行评估。通过单因素和多因素分析评估塌陷微血管比例与生存时间之间的相关性。

结果

分析了99例患者的数据,96例患者(1.4%-70%)的塌陷微血管比例范围较广。在单因素分析(P = 0.042)和多因素分析(P = 0.014)中,塌陷比例升高(⩾6.5%)均提示总生存期较差。

结论

塌陷微血管比例升高表明NSCLC患者的生存结局较差。

相似文献

1
Elevated proportion of collapsed microvessels indicate poor survival outcome in patients with non-small cell lung cancer.微脉管塌陷比例升高表明非小细胞肺癌患者的生存结局较差。
Tumori. 2019 Dec;105(6):494-500. doi: 10.1177/0300891619871103. Epub 2019 Sep 3.
2
Flattened microvessel independently predicts poor prognosis of patients with non-small cell lung cancer.扁平微血管独立预测非小细胞肺癌患者的不良预后。
Oncotarget. 2017 May 2;8(18):30092-30099. doi: 10.18632/oncotarget.15617.
3
Tumor angiogenesis in predicting the survival of patients with stage I lung cancer.肿瘤血管生成预测Ⅰ期肺癌患者的生存。
J Thorac Cardiovasc Surg. 2010 Nov;140(5):996-1000. doi: 10.1016/j.jtcvs.2010.07.002. Epub 2010 Aug 13.
4
Angiogenesis as a prognostic indicator of survival in non-small-cell lung carcinoma: a prospective study.血管生成作为非小细胞肺癌生存的预后指标:一项前瞻性研究。
J Natl Cancer Inst. 1997 Jun 18;89(12):881-6. doi: 10.1093/jnci/89.12.881.
5
Overexpression of S100A13 protein is associated with tumor angiogenesis and poor survival in patients with early-stage non-small cell lung cancer.S100A13 蛋白的过表达与早期非小细胞肺癌患者的肿瘤血管生成和不良预后相关。
Thorac Cancer. 2018 Sep;9(9):1136-1144. doi: 10.1111/1759-7714.12797. Epub 2018 Jul 26.
6
Mast cell phenotypes and microvessels in non-small cell lung cancer and its prognostic significance.非小细胞肺癌中的肥大细胞表型和微血管及其预后意义。
Hum Pathol. 2010 May;41(5):697-705. doi: 10.1016/j.humpath.2009.04.029. Epub 2009 Dec 29.
7
Comparative evaluation of angiogenesis assessment with anti-factor-VIII and anti-CD31 immunostaining in non-small cell lung cancer.抗VIII因子和抗CD31免疫染色评估非小细胞肺癌血管生成的比较性评价
Clin Cancer Res. 1997 Dec;3(12 Pt 1):2485-92.
8
Angiogenesis as a predictor of survival after surgical resection for stage I non-small-cell lung cancer.血管生成作为I期非小细胞肺癌手术切除后生存的预测指标。
J Thorac Cardiovasc Surg. 1998 Mar;115(3):652-8; discussion 658-9. doi: 10.1016/S0022-5223(98)70331-9.
9
[The influence of microvessel density in the tumor on the prognosis in patients with stage I-II non-small cell lung cancer after surgical treatment].[肿瘤微血管密度对Ⅰ-Ⅱ期非小细胞肺癌患者手术治疗后预后的影响]
Vopr Onkol. 2013;59(6):735-9.
10
Vascular endothelial growth factor, platelet-derived endothelial cell growth factor and angiogenesis in non-small-cell lung cancer.血管内皮生长因子、血小板衍生内皮细胞生长因子与非小细胞肺癌中的血管生成
Br J Cancer. 2000 Apr;82(8):1427-32. doi: 10.1054/bjoc.1999.1129.

引用本文的文献

1
Modified microvessel density based on perfusion distance: a preferable NSCLC prognostic factor.基于灌注距离的改良微血管密度:一种更优的非小细胞肺癌预后因素。
Ann Transl Med. 2022 Jan;10(2):43. doi: 10.21037/atm-21-6566.
2
Long Distance From Microvessel to Cancer Cell Predicts Poor Prognosis in Non-Small Cell Lung Cancer Patients.微血管与癌细胞之间的远距离预示非小细胞肺癌患者预后不良。
Front Oncol. 2021 Jun 11;11:632352. doi: 10.3389/fonc.2021.632352. eCollection 2021.